Article Details
Retrieved on: 2025-05-09 08:32:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NASDAQ: INMB) (the “Company”), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system, today ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here